Skip to Content
U.S. National Institutes of Health

NCI Awards in FY 2001 in Response to PAR-99-102 and PAR-99-103

(PAR-99-102 and PAR-99-103 are no longer active program announcements. They have been superseded by PAR-01-106, Applications of Innovative Technologies for the Molecular Analysis of Cancer: Phased Innovation Award, and PAR-01-107, Applications of Innovative Technologies for the Molecular Analysis of Cancer: SBIR/STTR.)

Would you like more information?

Abstracts of these funded grants are entered in the CRISP (Computer Retrieval of Information on Scientific Projects) database of federally funded biomedical research projects at http://crisp.cit.nih.gov/. This searchable database can be used to retrieve abstracts by grant number, principal investigator or other search terms. It also contains abstracts for grants funded in earlier fiscal years.

R21 and R33 Grants Awarded in Response to PAR-99-102, Applications of Innovative Technologies for the Molecular Analysis of Cancer: Phased Technology Application Award (R21/R33)

Nancy L Allbritton
Profiling Ras Activated Signal Transduction Pathways
University of California Irvine, Irvine, CA

Gerry R Boss
Automated Measurement of Ras & Rho Activation in Cancer
University of California San Diego, San Diego, CA

Brian T Chait
Comprehensive Map of Cellular Protein Interactions
Rockefeller University, New York, NY

Ronald W Davis
Target Identification via Haplo Insufficiency Profiling
Stanford University, Stanford, CA

David R Morris
Development of Translation State Array Analysis
University of Washington, Seattle, WA

Charles A Parkos
Phage Display and Prostate Neoplasia Progression
Emory University, Atlanta, GA

David W Speicher
Novel Comprehensive Proteome Analyses of Metastasis
Wistar Institute, Philadelphia, PA

Pengbo Zhou
Protein Knockout Technology/Molecular Analysis of Cancer
Weill Medical College of Cornell Univ, Ithaca, NY

R43 Grants Awarded in Response to PAR-99-103, Applications of Innovative Technologies for the Molecular Analysis of Cancer: SBIR/STTR Initiative

Suwanna Blair
Sigma-2 Receptor Radiotracers as SPECT Cancer Imaging Agents
Anasazi Biomedical Research, Inc., Winston-Salem, NC

Barbara J Hughey
Accelerator Mass Spect. Carcinogen & Anti-Cancer Markers
Newton Scientific, Inc., Cambridge, MA

Robert J Kinders
A New Marker for Colon Cancer Screening
Bion Diagnostic Sciences, Redmond, WA